Feb 20, 2020 4:10 pm EST VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update
Feb 18, 2020 4:10 pm EST VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update
Dec 5, 2019 8:30 am EST VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test
Nov 13, 2019 3:54 am EST VolitionRx Limited Announces Third Quarter 2019 Financial Results and Business Update
